We specialize in creating precise investment opportunities in the biotechnology space. Our first ETF, the Loncar Cancer Immunotherapy ETF (CNCR) is listed on Nasdaq.
Investing in Innovators
The CNCR ETF basket contains 25 companies, each with a unique perspective to cancer research. Watch our exclusive series of CEO interviews to learn more about the Cancer Immunotherapy ETF’s components and the important work these companies do.